PlainRecalls

Seaway Pharma Inc.

Compiled from official public sources by the publisher.

4 recalls on record · Latest: Jan 10, 2024

Subscribe to new Seaway Pharma Inc. recalls (RSS)

Agency notice ledger

Federal filing book Seaway Pharma Inc. LIGHT-BOOK · SINGLE-AGENCY

#3,171 of 14,151 · 4 notices · 0.004% archive

  • BOOK 4 notices
  • RANK #3,171 of 14,151
  • SHARE 0.004% archive
  • AGENCY FDA Drug (4)
  • CAT medical devices
  • CATS 2 categories
  • LATEST Jan 10, 2024
  • PHOTO 1 Epic, LLC

Nearest notice-volume peer: 1 Epic, LLC (0 notice gap)

Seaway Pharma Inc. accounts for about 0.004% of the 104,423-notice archive on 4 distinct filings — a light share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

Seaway Pharma Inc.'s standing among 14,151 recalling firms

Seaway Pharma Inc. ranks 3,171st of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Seaway Pharma Inc. vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

4 3171st of 14151 higher than 10,859 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-15

Seaway Pharma Inc. in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Seaway Pharma Inc. holds about 0.004% of archive notices alongside 4 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Moderate Jan 10, 2024

Quality Choice No Drip Extra Moisturizing Nasal Pump Mist Oxymetazoline hydrochloride 0.05%, 12 Hour Nasal Decongestant, 1 fl oz (30 mL) bottle, Distributed by C.D.M.A, Inc. 43157 W 9 Mile Rd. Novi, MI 48375, NDC# 63868-676-01, UPC 6-35515-98847-7.
FDA Drug Moderate Jan 10, 2024

Nasal Spray Original No Drip Oxymetazoline HCl Nasal Solution, 12 Hour Pump Mist, 1 FL oz. (30 mL) bottle, a) Quality Choice, Distributed by C.D.M.A. Inc., 43157 W 9 Mile Rd, Novi, MI 48375, NDC# 63868-607-01, UPC 6-35515-98843-9, b) Premier Value, Distributed by: Pharmacy Value Alliance, LLC, 407 East Lancaster Avenue, Wayne, PA 19087 UPC 8-40986-03509-8.
FDA Drug Moderate Jan 10, 2024

Quality Choice No Drip Severe Congestion Nasal Pump Mist, Oxymetazoline hydrochloride 0.05%, Nasal Decongestant, 12 Hours, 1 fl. oz. bottle, Distributed by C.D.M.A., Inc., 43157 W 9 Mile Rd., Novi, MI 48375, NDC 63868-608-01, UPC 6-35515-98846-0
FDA Drug Moderate Jan 10, 2024

Premier Value Tussin Cough DM, Dextromethorphan HBr...Cough Suppressant, Guaifenesin...Expectorant, Alcohol Free, 8 FL OZ (237 mL) bottle, Distributed by: Pharmacy Value Alliance, LLC, 407 East Lancaster Avenue, Wayne PA 19087, UPC 8-40986-03789-4.

Seaway Pharma Inc. is a small archive contributor

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar recall count

Nearest multi-notice firms by distinct-event totals (4 here).

1 Epic, LLC 4 3rd Day Beverages LLC 4 A.p. Deauville, LLC 4 Aaa Pharmaceutical, Inc. 4 Aap Implantate Ag 4

Similar medical devices volume

Nearest multi-notice firms that share this firm's dominant product category.

Aap Implantate Ag 4 Ab Sciex, LLC 4 Accelerate Diagnostics Inc 4 Accumetrics Inc 4

Frequently Asked Questions

How many federal recall notices name Seaway Pharma Inc.? ▼
PlainRecalls indexes 4 distinct federal recall events naming Seaway Pharma Inc., aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Seaway Pharma Inc. sit among other recalling firms? ▼
Seaway Pharma Inc. ranks #3,171 of 14,151 by distinct recall-event count among 14,151 firms in this archive (77th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Seaway Pharma Inc.'s notices? ▼
FDA Drug accounts for 4 of this firm's 4 indexed notices.
What product category dominates Seaway Pharma Inc.'s filing book? ▼
Filings for Seaway Pharma Inc. span 2 product categories, led by medical devices. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Seaway Pharma Inc.: 4 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Seaway Pharma Inc.; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026